Equity Details
Price & Market Data
Price: $10.55
Daily Change: -$1.06 / 10.05%
Daily Range: $10.53 - $12.65
Market Cap: $201,358,144
Daily Volume: 197,782
Performance Metrics
1 Week: -0.38%
1 Month: -2.68%
3 Months: 21.26%
6 Months: 18.94%
1 Year: 91.12%
YTD: 32.54%
About Elicio Therapeutics, Inc. (ELTX)
All about Elicio Therapeutics, Inc. (ELTX). Current price: 10.55, daily change: -$1.06 / 10.05%. Market cap: 201,358,144. Performance 1-week, 6-month, 1-year.
Company Details
Employees: 33
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trials for seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node-targeted AMP peptide treatment for mutant b-raf murine sarcoma viral oncogene homolog B1-(BRAF) driven cancers, and ELI-008, a multivalent lymph node-targeted AMP peptide vaccine in preclinical studies for the treatment of mutated tumor protein p53-expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.